Hot Performing Stocks To Own For 2019

A glance back over the years since the tantrum of 2013 casts today’s emerging-market ructions in a surprisingly rosy light.

It’s the fifth anniversary of the so-called taper tantrum — a bout of panic selling after Federal Reserve Chairman Ben Bernanke hinted at a reduction in stimulus. What followed was a sell-off that erased years of stimulus-led gains in currencies and stocks, spurring defaults globally.

But it didn’t last. When the Fed tightening actually began, developing-nations posted a turnaround and began outperforming the developed world.

Life After Taper Tantrum

Emerging markets are better off since Ben Bernanke's shocker exactly five years ago

Source: Bloomberg, JPMorgan Chase & Co., IHS Markit

.chart-js { display: none; } What happened?

Read the first account of the taper tantrum in this story from May 22, 2013

Hot Performing Stocks To Own For 2019: Internationa Flavors & Fragrances, Inc.(IFF)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on International Flavors & Fragrances (IFF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    International Flavors & Fragrances (NYSE:IFF) was downgraded by research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued on Wednesday.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on International Flavors & Fragrances (IFF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Tower Semiconductor Ltd. (NASDAQ: TSEM) fell 16.1 percent to $23.10 in pre-market trading after reporting downbeat quarterly results.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 13 percent to $18.00 in pre-market trading after declining 37.37 percent on Friday.
    Ability Inc. (NASDAQ: ABIL) shares fell 7.1 percent to $2.61 in pre-market trading.
    International Flavors & Fragrances Inc. (NYSE: IFF) shares fell 6.4 percent to $133.00 in pre-market trading. International Flavors & Fragrances reported upbeat earnings for its first quarter and agreed to acquire Frutarom for $7.1 billion.
    BHP Billiton Limited (NYSE: BHP) fell 6.8 percent to $45.00 in pre-market trading.
    Sibanye Gold Limited (NYSE: SBGL) fell 6.4 percent to $3.23 in pre-market trading after dropping 2.27 percent on Friday.
    Spark Therapeutics, Inc. (NASDAQ: ONCE) fell 5.9 percent to $66.52 in pre-market trading after declining 1.15 percent on Friday.
    DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares fell 4 percent to $48.00 in pre-market trading. DENTSPLY SIRONA reported Q1 adjusted earnings of $0.45 per share on sales of $956.1 million. The company updated its 2018 adjusted earnings guidance to $2.55 to 2.65 per share

Hot Performing Stocks To Own For 2019: Voyager Therapeutics, Inc.(VYGR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Chris Lange]

    For many drug developers, Parkinsons disease is a tricky disease to treat. However, developing a treatment ultimately could yield a huge reward as there are currently no therapies that effectively slow or reverse the progression of this disease. And after Thursdays announcement, Voyager Therapeutics Inc. (NASDAQ: VYGR) could be poised to reap this reward.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Voyager Therapeutics (VYGR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Voyager Therapeutics Inc. (NASDAQ: VYGR) will be presenting at the American Society of Gene and Cell Therapy annual meeting taking place May 16 to 19, 2018, in Chicago. The firm will be releasing data from its lead clinical program for Parkinsons disease, its preclinical programs targeting a monogenic form of amyotrophic lateral sclerosis (ALS) called SOD1, Huntingtons disease and Friedreichs ataxia, and its gene therapy vector platform including novel adeno-associated virus capsid optimization efforts and manufacturing capabilities.

  • [By Max Byerly]

    Voyager Therapeutics (NASDAQ:VYGR)’s share price was down 3.3% during trading on Tuesday . The company traded as low as $20.45 and last traded at $21.04. Approximately 9,445 shares traded hands during trading, a decline of 98% from the average daily volume of 399,751 shares. The stock had previously closed at $20.37.

Hot Performing Stocks To Own For 2019: Beasley Broadcast Group Inc.(BBGI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Beasley Broadcast Group (NASDAQ:BBGI) Director Mark S. Fowler sold 5,505 shares of the company’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $10.78, for a total value of $59,343.90. Following the sale, the director now owns 34,199 shares of the company’s stock, valued at $368,665.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Leave a Reply

Your email address will not be published. Required fields are marked *